Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Sell
207
-41
-17% -$65.3K 0.19% 97
2026
Q1
$493K Buy
248
+38
+18% +$52.1K 0.29% 85
2025
Q4
$225K Buy
+210
New +$219K 0.17% 104

Other funds holding ASML

WELLINGTON-ALTUS USA INC.'s ASML Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. reduced its ASML (ASML) stake by 17% in Q2 2026, selling an estimated $65.3K and leaving 207 shares worth $273K. The position accounts for 0.19% of the portfolio, ranked #97.

WELLINGTON-ALTUS USA INC. first reported a position in ASML in Q4 2025 and has held it in 3 quarters since. The position peaked at $493K in Q1 2026. 2,513 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 207 shares of ASML worth $273K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. sold 41 ASML shares in Q2 2026, an estimated $65.3K.
  • ASML made up 0.19% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #97 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in ASML in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s ASML position peaked at $493K in Q1 2026.
  • 2,513 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.